Limula: Funding, Investors & Team (Sep 2026)
Limula provides a unique platform technology enabling scale out of cell therapy production. Our patent-granted solution is combining a bioreactor and a centrifuge into one device, for the first time. Our product is composed of hardware, software and consumables, allowing healthcare providers to safely manufacture CGT in a decentralised manner. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments.
Limula has raised $12.6M across 7 funding rounds on record, the most recent an undisclosed round of $570k announced in Dec 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Limula Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Limula Funding Rounds
2 of 7 rounds were announced without a disclosed amount and are excluded from the total.
Limula raised $4.9M in a Grant announced in Jun 2022.
4 months later, a Seed was announced in Oct 2022 with no disclosed amount.
8 months later, an undisclosed round of $110k was announced in Jun 2023.
4 months later, an undisclosed round of $250k was announced in Oct 2023.
4 months later, an undisclosed round was announced in Feb 2024 with no disclosed amount.
3 months later, a Seed of $6.8M was announced in May 2024.
7 months later, an undisclosed round of $570k was announced in Dec 2024.
Limula Founders and Leadership Team
Contact details for the Limula team: 2 of 2 have an email address on file.
Start 14-day free trial →Limula Funding Compared to Other Biotechnology Startups
Limula's latest round of $570k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Limula in Biotechnology and La Tour-de-peilz
Companies Similar to Limula
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Limula Funding FAQs
What does Limula do?
Limula provides a unique platform technology enabling scale out of cell therapy production. Our patent-granted solution is combining a bioreactor and a centrifuge into one device, for the first time. Our product is composed of hardware, software and consumables, allowing healthcare providers to safely manufacture CGT in a decentralised manner. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments.
How much funding has Limula raised?
Limula has raised $12.6M across 7 rounds on record. The most recent is an undisclosed round of $570k announced in Dec 2024.
When did Limula last raise funding?
Limula's most recent funding round on record is an undisclosed round of $570k, announced in Dec 2024.
Who founded Limula?
FundedIQ lists Thomas Eaton (Founder), Yann Pierson (Founder) at Limula.
Where is Limula headquartered?
Limula is based in La Tour-de-peilz, Vaud, Switzerland.
How many employees does Limula have?
Limula is in the 1-10 employee band.
How does Limula's funding compare to other Biotechnology startups?
Limula's latest round of $570k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Limula Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Limula is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.